Long-term intravenous magnesium treatment for aneurysmal subarachnoid hemorrhage (SAH) – side effects and serum/CSF distribution

Christian Stetter, Jörg Eriskat, Ekkehard Kunze, Ralf-Ingo Ernestus & Thomas Westermaier
Objective: Increasing evidence suggests that SAH-patients benefit from intravenous magnesium treatment. We recently showed that magnesium sulfate can attenuate delayed vasospasm and increase the ischemic tolerance in case of cerebral vasospasm and perfusion deficits. However, a number of patients still[for full text, please go to the a.m. URL]